Sirrus
Company

Last deal

$5M

Amount

Series B

Stage

16.06.2016

Date

9

all rounds

$44.9M

Total amount

General

About Company
Sirrus develops innovative monomer platforms for adhesive, sealant, coating, ink, and plastic solutions.

Industry

Sector :

Subsector :

Also Known As

Bioformix

founded date

01.01.2009

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

Sirrus develops and supplies unique chemical building blocks for the next generation of high-performance coatings, adhesives, sealants, binders, and other polymer products. Their technology advances through chemistry relating to the synthesis, stabilization, activation, and formulation of a unique and reactive class of monomers commonly known as methylene malonates. The company's patented technology provides cure speeds at ambient temperatures, enabling manufacturing and assembly companies to significantly reduce cycle times, increase throughput, and reduce energy costs. Sirrus works with development partners in many industries to deliver new products that will enhance energy efficiency, safety, and performance and promise to be sustainably manufactured in the future.
Contacts